Samsung Electronics announced Thursday that a clinical study conducted jointly with Chung-Ang University Gwangmyeong Hospital ...

Submitted first clinical trial regulatory filing for CMP-002 in Australia, with additional global regulatory filings planned in 2026; anticipates initiation of global Phase 1/2 clinical trial in SYNGA ...

Announced positive ELEVATE-44-201 Cohort 1 topline results in Duchenne muscular dystrophy showing favorable safety, tolerability and early ...

For decades, relaxor ferroelectrics have powered everything from medical ultrasounds to sonar systems, yet their inner atomic ...

Achieved the primary objective with favorable safety and tolerability, no discontinuations and no serious adverse events ---- ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

A long-standing mystery in materials science is beginning to unravel as researchers directly probe the hidden atomic ...

Broadcast Retirement Network's Jeffrey Snyder discusses the latest approaches to Alzheimer's research with clinical ...

Unity Software Inc. ( U) Q1 2026 Earnings Call May 7, 2026 8:30 AM EDT Ladies and gentlemen, thank you for joining us, and welcome to the Unity Technologies Q1 Earnings Call. [Operator Instructions] ...

Preclinical studies have highlighted how (E,E)-bisantrene silences c-MYC gene expression via G4-DNA binding and stabilization leading to clinically relevant and broad anticancer activity ...

Announced positive ELEVATE-44-201 Cohort 1 topline results in Duchenne muscular dystrophy showing favorable safety, tolerability and early functional benefit -- -- Company on track to report ELEVATE-4 ...

Fortinet, Inc. ( FTNT) Q1 2026 Earnings Call May 6, 2026 4:30 PM EDT Anthony Luscri - Vice President of Investor Relations Ken Xie - Co-Founder, Chairman & CEO Christiane Ohlgart - Chief Accounting ...